Patient-reported hallucinations and the probability of progression to dementia in Parkinson’s disease
Objective: To evaluate the influence of neuropsychiatric symptoms in identifying Parkinson’s disease (PD) patients who will progress to dementia (PDD) in the imminent future (~4…Association of the GBA T369M polymorphism with motor and cognitive symptoms in Parkinson’s disease
Objective: To determine whether the GBA polymorphism T369M is associated with earlier age of onset, lower cognitive performance, and more severe motor impairment in Parkinson's…Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.
Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…Rationale and Design of a Phase 2 Study to Evaluate the Efficacy of Intepirdine (RVT-101) in Improving Gait and Balance in Patients with Dementia
Objective: To describe the rationale and design of a Phase 2 study that evaluates the effect of intepirdine (RVT-101) on gait and balance in patients…Cognitive decline in Parkinson’s disease: Impact on quality of life of caregivers
Objective: This study aimed to investigate the impact of cognitive impairment in Parkinson's disease (PD) on the quality of life (QoL) of carers. Background: The…Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?
Objective: To verify if the verbal trail test can replace the written trail test, seeing that individuals with PD show considerable motor abnormalities that can…Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…Life expectancy and dementia – Two sides of the coin in Parkinson’s disease
Objective: Our primary aim was to evaluate whether Parkinson's disease is associated with an increased risk of dementia and death. Background: The prevalence of Parkinson's…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 33
- Next Page »